CN Patent

CN110437223B — 乐伐替尼酸的噻唑酮衍生物及其应用

Assigned to Jiangsu Qianzhikang Biological Medicine Science And Technology Co ltd · Expires 2022-11-25 · 3y expired

What this patent protects

4‑[3‑氯‑4‑(环丙基氨基羰基)氨基苯氧基]‑7‑甲氧基‑6‑喹啉甲酰噻唑酮及其应用，结构符合通式(I) 该类药物在正常条件下药效较弱，在高自由基环境中不稳定，能够产生具有更强药效的分子。该类药物具有良好的药效和安全性，可用于治疗肿瘤药物的制备。

USPTO Abstract

4‑[3‑氯‑4‑(环丙基氨基羰基)氨基苯氧基]‑7‑甲氧基‑6‑喹啉甲酰噻唑酮及其应用，结构符合通式(I) 该类药物在正常条件下药效较弱，在高自由基环境中不稳定，能够产生具有更强药效的分子。该类药物具有良好的药效和安全性，可用于治疗肿瘤药物的制备。

Drugs covered by this patent

Patent Metadata

Patent number
CN110437223B
Jurisdiction
CN
Classification
—
Expires
2022-11-25
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Qianzhikang Biological Medicine Science And Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.